The World Health Organization (WHO) Global Diabetes Compact (GDC) was created as a global initiative to improve diabetes prevention and care, and to contribute to the global targets to reduce premature mortality due to noncommunicable diseases by one-third by 2030.
Le guide est disponible en 11 langüs:
arabe, allemand, anglais, francais, italien, polonais, russe, serbe, croate, espagnol, turc. Allez voir http://www.ethno-medizinisches-zentrum.de/index.php?option=com_content&view=article&id=37&Itemid=40
Diabetes is an increasingly prevalent yet under-recognised health crisis in Africa, driven by demographic and socioeconomic transitions. In 2021, 24 million adults in the region were living with diabetes, and this figure is expected to increase by 129% by 2045.
Diabetes poses an increasingly serious health challenge in Africa. Currently, 25 million adults aged 20–79 are living with diabetes, and this figure is projected to increase by 142% to 60 million by 2050 — the highest regional increase worldwide. However, 73% of cases remain undiagnosed, and hea...lthcare spending is the lowest worldwide at just USD 10 billion (1% of global expenditure). In 2024, diabetes caused 216,000 deaths and had a significant impact on maternal health, affecting 1 in 7 births due to hyperglycaemia during pregnancy. Nigeria, Tanzania and the Democratic Republic of the Congo have the highest case loads. Without urgent intervention, the diabetes burden will continue to grow, putting further strain on already limited health systems.
more
Tanzania has an estimated 2.9 million adults with diabetes, 35% of whom are undiagnosed, and over 22,000 people living with type 1 diabetes. While the 2023 Universal Health Insurance law aims to improve access to care, only 15% of people are insured. Over 700 clinics provide diabetes care and offer ...free insulin to children and young adults. However, challenges remain regarding insulin availability, diagnostics, patient education and the healthcare workforce. Community engagement, training and policy advocacy are essential for improving diabetes management and achieving universal health coverage.
more
Diabetic retinopathy affects over one-third of people with diabetes and is the leading cause of vision loss in working-age adults. Without effective intervention, the number of people with diabetic retinopathy will increase as global diabetes prevalence rises. Management and screening for diabetic r...etinopathy should begin in primary healthcare, where providers play a key role in educating patients, arranging eye examinations and referring patients for treatment if necessary.
more
If not properly managed, diabetes can lead to a wide range of serious health complications. These include retinopathy (eye damage), nephropathy (kidney damage), neuropathy (nerve damage) and damage to blood vessels. This increases the risk of heart disease, stroke, foot ulcers, infections and amputa...tions. Early diagnosis and consistent management through medication, a healthy diet, regular exercise and routine check-ups are critical to preventing or delaying these complications. Improving outcomes and reducing the long-term impact of diabetes in low-resource settings requires patient education and community health support.
Accessed on 17/07/2025.
more
This toolkit suggests several approaches to addressing technology
access disparities. At its core is a comprehensive checklist that helps
teams systematically evaluate their current practices and identify
opportunities for improvement. This structured self-assessment
tool spans both team-level a...ctions and organisational responsibilities,
recognising that change must occur at multiple levels
more
This handbook is designed to provide essential information as well as quick tips to improve foot care for people with dark skin tone living with diabetes.
Guía Clínica – Diabetes Mellitus tipo 1
Case Manangement Training Modules
The dual epidemic of TB and Diabetes
Updated 24 March 2020 (24 Maart 2020)
WHO Package of Essential NCD Interventions (PEN)
Accessed March 18,2019
Patients with diabetes are at increased risk of developing cardiovascular disease (CVD) with its manifestations of coronary artery disease (CAD), heart failure (HF), atrial fibrillation (AF), and stroke, as well as aortic and peripheral artery diseases. In addition, diabetes is a major risk factor f...or developing chronic kidney disease (CKD), which in itself is associated with developing CVD. The combination of diabetes with these cardio-renal comorbidities enhances the risk not only for cardiovascular (CV) events but also for CV and all-cause mortality. The current European Society of Cardiology (ESC) Guidelines on the management of cardiovascular disease in patients with diabetes are designed to guide prevention and management of the manifestations of CVD in patients with diabetes based on data published until end of January 2023. Over the last decade, the results of various large cardiovascular outcome trials (CVOTs) in patients with diabetes at high CV risk with novel glucose- lowering agents, such as sodium–glucose co-transporter-2 (SGLT2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists (RAs), but also novel non-steroidal mineralocorticoid receptor antagonists (MRAs), such as finerenone have substantially expanded available therapeutic op-
tions, leading to numerous evidence-based recommendations for the management of this patient population.
more